Wednesday, February 28, 2024 5:09:34 PM
========================================
About the pump piece. Anything italicized is a direct quote from the article posted on the Teslas ihub board
As the business world holds its breath
To kick off the article, it starts with the above. This statement implies there are more people interested in the events than is necessarily true. This is done to stimulate an emotional response in the reader.
is on the verge of announcing a significant corporate development, speculated to be a groundbreaking partnership or a strategic merger, causing its stock to soar in anticipation
Per the companies press release, they are adding a "promising corporate development" to their presentation. Nothing that indicates a major development or partnership. Also the promo piece claims the price is soaring in anticipation. The stock has not been soaring but it is up. This is hallmarks of pump and dump buy the rumor sell the news speculation and is meant to trigger FOMO in the reader.
The postponed shareholder call, initially set for January 11, hints at the imminent finalization of this deal, promising to shake the tech and automotive sectors.
It doesnt hint at the finalization of any such deal or shake the tech/automotive sectors. Again, the press release said they are adding a "promising corporate development" is all thats being claimed. This could something pertaining to R&D, but given the hype/pump pieces, i think there is some sort of financial deal to be disclosed and added to the presentation.
Anticipation Builds Around Corporate Development
The decision to delay the shareholder call suggests that <ticker omitted> is in the final stages of securing a deal that could redefine its corporate trajectory.
Again nothing to indicate this.
This development, coupled with the groundbreaking battery technology, has investors and industry observers on the edge of their seats.
Hyperbole meant to trigger FOMO in the reader. This is all part of the conartists ploy.
The nature of the corporate shift remains the subject of speculation, but the strategic postponement of the shareholder meeting indicates that the announcement will likely herald a new era for <ticker omitted> and its stakeholders.
Here the author of the article indicates this is just speculation as to protect themselves from potential liability. Thats then followed by speculation of the meeting to again try and trigger an emotional response and encourage FOMO.
Let me first just say that this pump piece is nowhere grounded in reality nor does it provide any evidence to support its speculation. The only thing that is grounded is the postponed meeting where the company will add a promising new development. However nothing to indicate the included information will be on the level major significant corporate announcement.
========================================
Lets contrast this with the information i post. I speculate, i acknowledge that. The major difference is my speculation is grounded in real evidence which i share so you can verify. I try to get other posters to engage with me so i can better refine my speculation and better understand whats going on, but i cannot get their help.
Now anyone reading my posts that i claim that Zimmer Biomet is a stakeholder in Sintx and has been since it acquired Centerpulse in 2003 could see that as being false statement. However, I make this claim based on the following evidence:
Shared IP in development:
Sintx femoral head tested against Biomet's E1 liner
https://ir.sintx.com/news-events/press-releases/detail/95/amedica-announces-results-of-independent-femoral-head-wear
Si3N4 coating of Biomet's OsseoTI Acetabular shell
https://www.sciencedirect.com/science/article/abs/pii/S1751616119309099
Shared Personnel:
Dr Sonny Bal, MD, JD, MBA, PHD (Chairman, CEO) was a member of Zimmers designer: Designer Surgeon Panel, Zimmer Inc., Warsaw, Indiana, 2002 to present.
http://www.hipandknee.com/wp-content/uploads/sites/13/2014/04/Dr.-Bal-CV.pdf (link no longer valid)
Dr Link, PHD (Chairman 2003-2014) - Dr. Link served as Chairman of the Board and Chief Executive Officer of Centerpulse AG, the largest orthopedics company in Europe, from March 2002 until October 2003, when Centerpulse was acquired by Zimmer Holdings, Inc
Dr Hofmann, MD (Co-founder/former director) - Dr. Hofmann, working with a team of orthopedic surgeons, helped design Zimmer’s new gender knee specifically designed for women
Whats not included is that Dr Hofmann worked for Centerpulse before its acquisition. So Hofmann & Link both came from Centerpulse originally but both connected to Zimmer post acquisition. You can see a continuity that spans the life of Sintx.
https://www.sec.gov/Archives/edgar/data/1269026/000119312507120692/ds1.htm pg 73/74 under management section.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology • GlobeNewswire Inc. • 06/06/2024 01:00:00 PM
- SINTX TECHNOLOGIES SIGNS AGREEMENT TO ENTER KOREAN TECHNICAL CERAMICS SECTOR • GlobeNewswire Inc. • 05/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 01:10:13 PM
- SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024 • GlobeNewswire Inc. • 05/23/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 01:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 09:20:34 PM
- SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT • GlobeNewswire Inc. • 04/29/2024 01:14:20 PM
- SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock • GlobeNewswire Inc. • 04/03/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/29/2024 08:00:00 PM
- SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock • GlobeNewswire Inc. • 03/25/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET • GlobeNewswire Inc. • 02/21/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 02:00:28 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:12:54 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/07/2024 09:42:32 PM
- SINTX Technologies Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 02/02/2024 07:33:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 11:30:20 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/01/2024 10:14:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/01/2024 05:15:22 AM
- SINTX Technologies Announces Pricing of $4.0 Million Public Offering • GlobeNewswire Inc. • 01/31/2024 02:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 11:05:14 AM
- SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY • GlobeNewswire Inc. • 01/30/2024 09:01:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:16:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:05:13 PM
- SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE • GlobeNewswire Inc. • 01/23/2024 02:00:00 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM